To the Editor: In the context of growing herpes simplex virus (HSV) resistance to licensed antiviral agents targeting HSV DNA polymerase,1 especially HSV resistance to acyclovir in immunocompromise...
CITATION STYLE
Burrel, S., Rouard, C., & Boutolleau, D. (2014). Helicase–Primase Inhibitor Pritelivir for HSV-2 Infection. New England Journal of Medicine, 370(17), 1663–1664. https://doi.org/10.1056/nejmc1402071
Mendeley helps you to discover research relevant for your work.